Literature DB >> 33936095

Cholinergic System and Its Therapeutic Importance in Inflammation and Autoimmunity.

Namrita Halder1, Girdhari Lal1.   

Abstract

Neurological and immunological signals constitute an extensive regulatory network in our body that maintains physiology and homeostasis. The cholinergic system plays a significant role in neuroimmune communication, transmitting information regarding the peripheral immune status to the central nervous system (CNS) and vice versa. The cholinergic system includes the neurotransmitter\ molecule, acetylcholine (ACh), cholinergic receptors (AChRs), choline acetyltransferase (ChAT) enzyme, and acetylcholinesterase (AChE) enzyme. These molecules are involved in regulating immune response and playing a crucial role in maintaining homeostasis. Most innate and adaptive immune cells respond to neuronal inputs by releasing or expressing these molecules on their surfaces. Dysregulation of this neuroimmune communication may lead to several inflammatory and autoimmune diseases. Several agonists, antagonists, and inhibitors have been developed to target the cholinergic system to control inflammation in different tissues. This review discusses how various molecules of the neuronal and non-neuronal cholinergic system (NNCS) interact with the immune cells. What are the agonists and antagonists that alter the cholinergic system, and how are these molecules modulate inflammation and immunity. Understanding the various functions of pharmacological molecules could help in designing better strategies to control inflammation and autoimmunity.
Copyright © 2021 Halder and Lal.

Entities:  

Keywords:  choline acetyltransferase (ChAT); cholinergic system (CS); muscarinic acetylcholine receptors (mAChR); neuroimmunology; neurotransmitters; nicotinic acetylcholine receptors (nAChR)

Year:  2021        PMID: 33936095      PMCID: PMC8082108          DOI: 10.3389/fimmu.2021.660342

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  405 in total

1.  The effects of morphine, nicotine and epibatidine on lymphocyte activity and hypothalamic-pituitary-adrenal axis responses.

Authors:  R D Mellon; B M Bayer
Journal:  J Pharmacol Exp Ther       Date:  1999-02       Impact factor: 4.030

2.  Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.

Authors:  Da-wei Wang; Rong-bin Zhou; Yong-ming Yao; Xiao-mei Zhu; Yi-mei Yin; Guang-ju Zhao; Ning Dong; Zhi-yong Sheng
Journal:  J Pharmacol Exp Ther       Date:  2010-09-15       Impact factor: 4.030

3.  Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial.

Authors:  M Rösler; R Anand; A Cicin-Sain; S Gauthier; Y Agid; P Dal-Bianco; H B Stähelin; R Hartman; M Gharabawi
Journal:  BMJ       Date:  1999-03-06

4.  MicroRNA-132 modulates cholinergic signaling and inflammation in human inflammatory bowel disease.

Authors:  Nitsan Maharshak; Shani Shenhar-Tsarfaty; Nimrod Aroyo; Naama Orpaz; Irene Guberman; Jonathan Canaani; Zamir Halpern; Iris Dotan; Shlomo Berliner; Hermona Soreq
Journal:  Inflamm Bowel Dis       Date:  2013-06       Impact factor: 5.325

5.  Nicotine-mediated signals modulate cell death and survival of T lymphocytes.

Authors:  Silvia C S Oloris; Ashley A Frazer-Abel; Cristan M Jubala; Susan P Fosmire; Karen M Helm; Sally R Robinson; Derek M Korpela; Megan M Duckett; Shairaz Baksh; Jaime F Modiano
Journal:  Toxicol Appl Pharmacol       Date:  2009-11-04       Impact factor: 4.219

6.  7,8-Dihydroxyflavone attenuates the release of pro-inflammatory mediators and cytokines in lipopolysaccharide-stimulated BV2 microglial cells through the suppression of the NF-κB and MAPK signaling pathways.

Authors:  Hye Young Park; Cheol Park; Hye Jin Hwang; Byung Woo Kim; Gi-Young Kim; Cheol Min Kim; Nam Deuk Kim; Yung Hyun Choi
Journal:  Int J Mol Med       Date:  2014-02-10       Impact factor: 4.101

7.  Neurotransmitter suppression of the in vitro generation of a cytotoxic T lymphocyte response against the syngeneic MOPC-315 plasmacytoma.

Authors:  J M Cook-Mills; M B Mokyr; R L Cohen; R L Perlman; D A Chambers
Journal:  Cancer Immunol Immunother       Date:  1995-02       Impact factor: 6.968

8.  Phorbol ester stimulates acetylcholine synthesis in cultured endothelial cells isolated from porcine cerebral microvessels.

Authors:  C Ikeda; I Morita; A Mori; K Fujimoto; T Suzuki; K Kawashima; S Murota
Journal:  Brain Res       Date:  1994-08-29       Impact factor: 3.252

9.  A novel CMKLR1 small molecule antagonist suppresses CNS autoimmune inflammatory disease.

Authors:  Kareem L Graham; Jian V Zhang; Susanna Lewén; Thomas M Burke; Ton Dang; Maria Zoudilova; Raymond A Sobel; Eugene C Butcher; Brian A Zabel
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

10.  The M3 muscarinic receptor is required for optimal adaptive immunity to helminth and bacterial infection.

Authors:  Matthew Darby; Corinna Schnoeller; Alykhan Vira; Fiona Jane Culley; Fiona Culley; Saeeda Bobat; Erin Logan; Frank Kirstein; Jürgen Wess; Adam F Cunningham; Frank Brombacher; Murray E Selkirk; William G C Horsnell
Journal:  PLoS Pathog       Date:  2015-01-28       Impact factor: 6.823

View more
  14 in total

Review 1.  α7 nicotinic acetylcholine receptors in the hippocampal circuit: taming complexity.

Authors:  Ayland C Letsinger; Zhenglin Gu; Jerrel L Yakel
Journal:  Trends Neurosci       Date:  2021-12-13       Impact factor: 13.837

2.  Minocycline Ameliorates Chronic Unpredictable Mild Stress-Induced Neuroinflammation and Abnormal mPFC-HIPP Oscillations in Mice.

Authors:  Sidra Tabassum; Afzal Misrani; Qingwei Huo; Adeel Ahmed; Cheng Long; Li Yang
Journal:  Mol Neurobiol       Date:  2022-09-01       Impact factor: 5.682

Review 3.  Neuroimmunometabolism: A New Pathological Nexus Underlying Neurodegenerative Disorders.

Authors:  Swarup Mitra; Avijit Banik; Sumit Saurabh; Malabika Maulik; Shailesh N Khatri
Journal:  J Neurosci       Date:  2022-01-13       Impact factor: 6.709

Review 4.  Neurokinin receptors and their implications in various autoimmune diseases.

Authors:  Amrita Mishra; Girdhari Lal
Journal:  Curr Res Immunol       Date:  2021-07-01

Review 5.  Role of adrenergic receptor signalling in neuroimmune communication.

Authors:  Sushanta Chhatar; Girdhari Lal
Journal:  Curr Res Immunol       Date:  2021-11-25

6.  Cholinergic anti-inflammatory pathway and COVID-19.

Authors:  Danial Mehranfard; Robert C Speth
Journal:  Bioimpacts       Date:  2022-01-22

Review 7.  Acrylamide Neurotoxicity as a Possible Factor Responsible for Inflammation in the Cholinergic Nervous System.

Authors:  Marta Kopańska; Anna Łagowska; Barbara Kuduk; Agnieszka Banaś-Ząbczyk
Journal:  Int J Mol Sci       Date:  2022-02-12       Impact factor: 5.923

Review 8.  Parental smoking, type 1 diabetes, and islet autoantibody positivity in the offspring: A systematic review and meta-analysis.

Authors:  Jessica Edstorp; Anna-Maria Lampousi; Sofia Carlsson
Journal:  Diabet Med       Date:  2022-03-29       Impact factor: 4.213

9.  Metabolomics profile in acute respiratory distress syndrome by nuclear magnetic resonance spectroscopy in patients with community-acquired pneumonia.

Authors:  Yongqin Yan; Jianuo Chen; Qian Liang; Hong Zheng; Yiru Ye; Wengang Nan; Xi Zhang; Hongchang Gao; Yuping Li
Journal:  Respir Res       Date:  2022-06-27

10.  Maternal smoking during pregnancy and type 1 diabetes in the offspring: a nationwide register-based study with family-based designs.

Authors:  Yuxia Wei; Tomas Andersson; Jessica Edstorp; Josefin E Löfvenborg; Mats Talbäck; Maria Feychting; Sofia Carlsson
Journal:  BMC Med       Date:  2022-08-12       Impact factor: 11.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.